ADVERTISMENT
Watch as dermatologist Dr. Day explores how precision medicine and IL-13 insights are reshaping atopic dermatitis care.
Featured Content
Article
Setting long-term treatment goals in atopic dermatitis: aligning clinical control with patient prioritiesFrom flare suppression to sustained disease control
Article
Beyond body surface area: recognizing high-burden atopic dermatitis in skin of colorCurrent quality-of-life impact and treatment needs may be underestimated
Article
The science of selective il-13 inhibition: moving towards systemic management in atopic dermatitisMechanistic insights reveal opportunities for disease modification through precision targeting
Article
Recognizing and addressing disparities in atopic dermatitis management: the imperative for equitable careSystematic barriers perpetuate undertreatment in patients with skin of color
Article
Strategic patient selection for il-13 targeted therapy: biomarkers and clinical phenotypesPrecision medicine approaches optimize treatment outcomes in moderate-to-severe atopic dermatitis
Article
Reframing treatment goals in atopic dermatitis: from exacerbation management to disease modificationTargeted systemic therapies enable sustained control and long-term remission
ADVERTISMENT






